251 related articles for article (PubMed ID: 25572822)
1. Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily member TRAIL in breast cancer.
Lv S; Wang X; Zhang N; Sun M; Qi W; Li Y; Yang Q
Int J Oncol; 2015 Mar; 46(3):1286-94. PubMed ID: 25572822
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells.
Monma H; Iida Y; Moritani T; Okimoto T; Tanino R; Tajima Y; Harada M
PLoS One; 2018; 13(3):e0193990. PubMed ID: 29513749
[TBL] [Abstract][Full Text] [Related]
3. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab.
Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
PLoS One; 2009 Jul; 4(7):e6251. PubMed ID: 19606230
[TBL] [Abstract][Full Text] [Related]
4. Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline.
Zinnah KMA; Park SY
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080659
[TBL] [Abstract][Full Text] [Related]
5. Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway.
Nazim UM; Yin H; Park SY
Int J Oncol; 2020 May; 56(5):1152-1161. PubMed ID: 32319589
[TBL] [Abstract][Full Text] [Related]
6. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
Singh K; Sharma A; Mir MC; Drazba JA; Heston WD; Magi-Galluzzi C; Hansel D; Rubin BP; Klein EA; Almasan A
Mol Cancer; 2014 Mar; 13():70. PubMed ID: 24655592
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia‑mediated activation of autophagic flux inhibits apoptosis of keratinocytes via blocking tumor necrosis factor‑related apoptosis‑inducing ligand.
Kim SW; Park SY
Mol Med Rep; 2016 Jan; 13(1):805-10. PubMed ID: 26648440
[TBL] [Abstract][Full Text] [Related]
8. 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5.
Chen Y; Wei L; Zhang X; Liu X; Chen Y; Zhang S; Zhou L; Li Q; Pan Q; Zhao S; Liu H
Oncol Rep; 2018 Nov; 40(5):2435-2444. PubMed ID: 30132536
[TBL] [Abstract][Full Text] [Related]
9. Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis.
Nazim UM; Moon JH; Lee JH; Lee YJ; Seol JW; Eo SK; Lee JH; Park SY
Oncotarget; 2016 Apr; 7(17):23468-81. PubMed ID: 26992204
[TBL] [Abstract][Full Text] [Related]
10. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
[TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibitors regulate TRAIL sensitivity in human malignant cells by targeting the mitochondrial network and calcium dynamics.
Onoe-Takahashi A; Suzuki-Karasaki M; Suzuki-Karasaki M; Ochiai T; Suzuki-Karasaki Y
Int J Oncol; 2019 May; 54(5):1734-1746. PubMed ID: 30896851
[TBL] [Abstract][Full Text] [Related]
12. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
13. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
14. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
[TBL] [Abstract][Full Text] [Related]
15. Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death.
Moon JH; Eo SK; Lee JH; Park SY
Oncol Rep; 2015 Jul; 34(1):375-81. PubMed ID: 25997470
[TBL] [Abstract][Full Text] [Related]
16. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.
Ryabaya OO; Inshakov AN; Egorova AV; Emelyanova MA; Nasedkina TV; Zasedatelev AS; Khochenkov DA; Stepanova EV
Anticancer Drugs; 2017 Mar; 28(3):307-315. PubMed ID: 27941537
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human gastric cancer cells through downregulating JNK-mediated cytoprotective autophagy.
Xu Y; Wang Q; Zhang L; Zheng M
Cancer Chemother Pharmacol; 2018 Mar; 81(3):555-564. PubMed ID: 29383484
[TBL] [Abstract][Full Text] [Related]
18. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
[TBL] [Abstract][Full Text] [Related]
19. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.
Zhang SF; Wang XY; Fu ZQ; Peng QH; Zhang JY; Ye F; Fu YF; Zhou CY; Lu WG; Cheng XD; Xie X
Autophagy; 2015; 11(2):225-38. PubMed ID: 25607466
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment.
Qin L; Xu T; Xia L; Wang X; Zhang X; Zhang X; Zhu Z; Zhong S; Wang C; Shen Z
Drug Des Devel Ther; 2016; 10():1035-45. PubMed ID: 27022243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
